Biohaven (BHVN) Total Current Liabilities (2021 - 2026)

Biohaven (BHVN) posted Total Current Liabilities of $52.1 million for Q1 2026, down 55.08% sequentially from $115.9 million in Q4 2025, and down 68.25% YoY from $164.0 million in Q1 2025.

Biohaven (BHVN) Total Current Liabilities (2021 - 2026) Analysis & Trends

Biohaven has reported Total Current Liabilities for 6 years, with the latest figure at $52.1 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 68.25% year-over-year to $52.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.1 million (down 68.25% YoY) and the FY2025 annual result came in at $115.9 million, down 24.83% from the prior year.
  • Total Current Liabilities eased to $52.1 million in Q1 2026 per BHVN's latest filing, from $115.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $164.0 million in Q1 2025 and troughed at $28.4 million in Q3 2022.
  • A 5-year average of $103.8 million and a median of $113.0 million in 2025 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Current Liabilities jumped 178.27% in 2024, then plunged 68.25% in 2026.
  • Over 5 years, Total Current Liabilities stood at $90.0 million in 2022, then plunged by 38.43% to $55.4 million in 2023, then surged by 178.27% to $154.2 million in 2024, then dropped by 24.83% to $115.9 million in 2025, then sank by 55.08% to $52.1 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $52.1 million, $115.9 million, and $113.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Biohaven 2.21 Bn 1.94 Bn - 62.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 62.66 Mn
Mar 31, 2026 52.08 Mn
Dec 31, 2025 115.93 Mn
Sep 30, 2025 113.02 Mn
Jun 30, 2025 124.32 Mn
Mar 31, 2025 164.03 Mn
Dec 31, 2024 154.23 Mn
Sep 30, 2024 152.29 Mn
Jun 30, 2024 156.21 Mn
Mar 31, 2024 86.59 Mn
Dec 31, 2023 55.42 Mn
Sep 30, 2023 62.18 Mn
Jun 30, 2023 87.85 Mn
Mar 31, 2023 114.01 Mn
Dec 31, 2022 90.02 Mn
Sep 30, 2022 28.44 Mn
Dec 31, 2021 41.94 Mn